Yann Echelard
CIK: 0001561958
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TG THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 11, 2026TGTX
TG THERAPEUTICS, INC.
Award(A)DirectStock Tracking Unit
8.3K shares- - Nov 24, 2025TGTX
TG THERAPEUTICS, INC.
Sale(S)Direct5K shares at avg. $32.57$163K - Jun 13, 2025TGTX
TG THERAPEUTICS, INC.
Sale(S)Direct10K shares at avg. $36.94$369K - Jun 12, 2025TGTX
TG THERAPEUTICS, INC.
Award(A)Direct14.7K shares- - Nov 5, 2024TGTX
TG THERAPEUTICS, INC.
Sale(S)Direct20K shares at avg. $24.48$490K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | TGTX TG THERAPEUTICS, INC. | Award(A) Stock Tracking Unit | 8,325 | - | - | Direct |
| Nov 24, 2025 | TGTX TG THERAPEUTICS, INC. | Sale(S) | 5,000 | $32.57 | $162,850 | Direct |
| Jun 13, 2025 | TGTX TG THERAPEUTICS, INC. | Sale(S) | 10,000 | $36.94 | $369,400 | Direct |
| Jun 12, 2025 | TGTX TG THERAPEUTICS, INC. | Award(A) | 14,718 | - | - | Direct |
| Nov 5, 2024 | TGTX TG THERAPEUTICS, INC. | Sale(S) | 20,000 | $24.48 | $489,600 | Direct |
1-5 of 5 transactions
About Echelard Yann
Echelard Yann (SEC CIK 0001561958) files insider reports with the SEC as Director of TG THERAPEUTICS, INC. (TGTX).
Signal8 holds 4 ownership filings by Echelard Yann, all Form 4s, filed between Nov 7, 2024 and Jun 15, 2026. Those filings report 5 transactions, from Nov 5, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Echelard Yann's filings is in MORRISVILLE, NC.
Recent filings by Echelard Yann
- Jun 11, 2026: Grant or award of TGTX derivative securities (Form 4, code A).
- Nov 24, 2025: Open-market sale of TGTX shares (Form 4, code S).
- Jun 13, 2025: Open-market sale of TGTX shares (Form 4, code S).
- Jun 12, 2025: Grant or award of TGTX shares (Form 4, code A).
- Nov 5, 2024: Open-market sale of TGTX shares (Form 4, code S).
Other insiders filing for TG THERAPEUTICS, INC. (TGTX)
- Charney Laurence N, Director
- Lonial Sagar, Director
- HUME DANIEL, Director
- Hoberman Kenneth, Director
- WEISS MICHAEL S, CEO
- Power Sean A, CFO